Note: AntiCP 2.0 an updated model for predicting anticancer (ACP) peptides_2020
Note: AntiCP 2.0 an updated model for predicting anticancer (ACP) peptides_2020 doi: 10.1093/bib/bbaa153 In silico model development; predicting and designing anticancer peptides Preference Amino acids A, F, K, L and W Position A, F and K favour at N-terminal L and K favour at C-terminal Motif LAKLA AKLAK FAKL LAKL Machine model (tree-based model) Web server: https://webs.iiitd.edu.in/raghava/anticp2/ -- Content What they claim why peptides are good for treating cancer .. High target specificity Good efficacy Easily to synthesized Low toxicity Easily to be chemically modified Less immunogenic compared to recombinant antibodies -- >60 drugs have been approved by FDA >500 under clinical trials -- ACP is part of the antimicrobial peptide 5-50 AA Cationic Mostly, alpha-helix Some, beta-sheet Some, linear Cancer cell mb Larger surface area (microvilli by nature) Negatively charged Higher fluidity Dataset to generate model ACP-DL , ACPP , ACPred-FL , AntiCP , iACP peptide , CancerPPD